Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Ms. Cristin HubbardExec. VP & Chief Commercial Officer | -2,32k | 116,36k | Sale to Issuer | 50,20 | 7,38k | -23,89% |
| 2026-05-07 | Dr. Gregory FribergExec. VP and Chief Research & Development Officer | -3,28k | 176,68k | Vendita | 53,85 | 51,82k | -5,95% |
| 2026-03-18 | Mr. George Eric DavisExec. VP, Chief Legal Officer & Secretary | -1,27k | 71,35k | Sale to Issuer | 56,05 | 78,56k | -1,59% |
| 2026-03-17 | Dr. C. Greg GuyerExec. VP & CTO | -1,69k | 94,89k | Sale to Issuer | 56,05 | 74,16k | -2,23% |
| 2026-03-17 | Mr. Brian R. MuellerCFO & Exec. VP of Finance | -2,12k | 118,66k | Sale to Issuer | 56,05 | 123,31k | -1,69% |
| 2026-03-17 | Mr. Alexander HardyPresident, CEO & Director | -4,25k | 238,32k | Sale to Issuer | 56,05 | 214,64k | -1,94% |
| 2026-03-17 | Ms. Cristin HubbardExec. VP & Chief Commercial Officer | -1,25k | 69,78k | Sale to Issuer | 56,05 | 7,58k | -14,11% |
| 2026-03-17 | Dr. Gregory FribergExec. VP and Chief Research & Development Officer | -1,63k | 91,31k | Sale to Issuer | 56,05 | 55,10k | -2,87% |
| 2026-03-13 | Dr. C. Greg GuyerExec. VP & CTO | -9,11k | 532,97k | Sale to Issuer | 58,51 | 50,07k | -15,39% |
| 2026-03-16 | Mr. George Eric DavisExec. VP, Chief Legal Officer & Secretary | -7,18k | 419,93k | Sale to Issuer | 58,51 | 79,83k | -8,25% |
| 2026-03-13 | Mr. Brian R. MuellerCFO & Exec. VP of Finance | -9,95k | 581,88k | Sale to Issuer | 58,51 | 125,43k | -7,35% |
| 2026-03-16 | Mr. Alexander HardyPresident, CEO & Director | -2,94k | 172,08k | Sale to Issuer | 58,51 | 77,49k | -3,66% |
| 2026-03-11 | Dr. C. Greg GuyerExec. VP & CTO | -16,49k | 996,74k | Vendita | 60,46 | 44,58k | -27,00% |
| 2026-02-26 | Dr. Gregory FribergExec. VP and Chief Research & Development Officer | -6,33k | 381,94k | Vendita | 60,38 | 37,58k | -14,41% |
| 2026-02-26 | Mr. George Eric DavisExec. VP, Chief Legal Officer & Secretary | -26,06k | 1,60M | Vendita | 61,36 | 72,45k | -26,45% |
| 2025-12-30 | Mr. Richard A. MeierInsider | -500,00 | 0,00 | Other Disposition | - | 120,28k | -0,41% |
| 2025-12-01 | Mr. Alexander HardyPresident, CEO & Director | -16,57k | 911,85k | Sale to Issuer | 55,03 | 40,65k | -28,96% |
| 2025-09-30 | Dr. Gregory FribergExec. VP and Chief Research & Development Officer | -3,30k | 178,94k | Sale to Issuer | 54,16 | 43,51k | -7,06% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
